Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-080869

Chief Scientific Officer sold 52,448 shares at an average $20.02 ($1,049,960)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-21 Sale : show line 1 in the form 10b5-1 −50,000 $20.02 $1,001,000 2,714,746 I
2026-07-22 Sale : show line 2 in the form 10b5-1 −2,448 $20.00 $48,960 2,712,298 I
Open-market sales · 52,448 sh · avg $20.02 · $1,049,960
Loading xslF345X06/ownership.xml…